Postpartum Haemorrhage: Global Health Recommendations

Summary of WHO Guidelines on Postpartum Hemorrhage (PPH)

This article ‍details‍ new guidelines from the World ⁣Health Institution (WHO), the International Federation of Gynecology and Obstetrics‍ (FIGO), and the International Confederation of Midwives (ICM) aimed at preventing, diagnosing, and treating Postpartum Hemorrhage⁤ (PPH) – excessive bleeding after childbirth.PPH is a leading cause of maternal mortality globally, causing‍ nearly 45,000 deaths annually and leading to notable health impacts even when not fatal.

Key takeaways:

* Earlier Detection is Crucial: The guidelines lower the diagnostic ⁣threshold for⁣ PPH from 500mL to 300mL of blood loss when accompanied by⁣ abnormal vital signs. This emphasizes⁣ the need for rapid response, as PPH can escalate quickly.
*⁣ Improved Diagnostic Tools: Clinicians are advised to use calibrated drapes to accurately measure blood loss.
* MOTIVE Bundle for Immediate Action: Upon diagnosis, the MOTIVE bundle should be instantly implemented:
* Massage of the uterus
* Oxytocic drugs
* Tranexamic ⁢acid (TXA)
* ⁢ Intravenous fluids
* Vaginal⁣ and genital tract examination
* Escalation of care if bleeding persists
* Prevention is Key: The guidelines highlight the importance of addressing risk factors like anemia through⁣ antenatal ‍and postnatal care, including⁤ iron and folate supplementation and, when necessary, intravenous iron transfusions.
* Focus on Resource-Limited ⁢Settings: The guidelines are designed⁢ to be impactful even in areas with limited ‍healthcare resources,aiming ⁢to improve survival rates and ensure women can safely return home after childbirth.

In essence, the new guidelines⁣ represent a shift towards proactive readiness, early recognition, ‍and ⁣rapid response to PPH, with the goal of substantially reducing maternal mortality and morbidity.